Ann: Change of Director's Interest Notice, page-152

I am more chilled on the next quarterly, although obviously we would all like to see a good number. It is hard for us to quantify just what is a 'good' number though. Of more importance to me is validation by way of a revenue producing contract with a foreign based telehealth provider. Don't lose track of the UK Director, Sales and Marketing. To refresh our memories about Europe:



The only negative for me is the recent spike in UK COVID figures which may delay the evaluation studies. On the flip side we can demonstrate that DX works well in triaging COVID sufferers as per the Morayfield COVID Clinic in Brisbane.